AFT Pharmaceuticals Health Care
Pharmaceuticals

$3.400 (0%)

High -	Low -	Trades -	Turnover $0	Volume 0
3 July 2025 at 4:47am

Register to track AFP and receive email alerts.

Market Cap (1-Jul) $275,671,360 (480th)	Close (30-Jun) $3.40 0 (0%)	Volume (30-Jun) 0	Shortsold (6-Aug) 667 (0.00%) (670th)
52w High $3.12	52w Low $2.13	P/E 20.92	EPS 0.1
ASX Announcements (7d) -	Twitter Mentions (7d) 0+	AFR Articles (7d) -	News Articles (7d) 2+

	Subject
	AFP AFP Ann: change of capital notice
	1 (current) 2 3
	AFP AFP Ann: Application for quotation of securities - AFP
	AFP AFP Ann: Officers interest
	AFP AFP Ann: capital change notice
	AFP AFP Ann: AFP to announce full year results on Monday May 23 2022
	AFP AFP Ann: Application for quotation of securities - AFP
	AFP AFP Ann: Capital Change Notice
	AFP AFP Ann: AFT prevails in comparative advertising judgement
	AFP AFP Ann: AFT notes FDA approval for Pascomer alternative
	AFP AFP Ann: FFC: Farmaforce and AFT Pharmaceuticals Partnership
	AFP AFP Ann: Disclosure of Directors & Senior Managers Relevant Interests
	AFP AFP Ann: 2022 New Year letter to investors
	AFP AFP Ann: Disclosure of Directors and Senior Managers Relevant Interes
	AFP AFP Ann: Application for quotation of securities - AFP
	AFP AFP Ann: AFT welcomes Australian Federal Court appeal success
	AFP AFP Ann: amended capital notice
	AFP AFP Ann: Application for quotation of securities - AFP
	AFP AFP Ann: capital change notice
	AFP AFP Ann: Presentation Slide 16 Correction
	AFP AFP Ann: 211118 AFT Interim Announcement FY2022 App2
	AFP AFP Ann: 211118 AFT Interim Financial Statements FY22
	AFP AFP Ann: 211118 AFT FY 22 Interim Result Investor Presentation
	AFP AFP Ann: 211118 AFT 1H FY22 Market Release
	AFP AFP Ann: FDA confirms earlier than expected PDUFA date for Maxigesic
	AFP AFP Ann: AFT appoints McPhersons as Singapore distributor
	AFP AFP Ann: US FDA accepts Maxigesic IV New Drug Application
	AFP AFP Ann: Maxigesic IV registered in the UK and Ireland
	AFP AFP Ann: half year interim results announcement 18 Nov 2021
	AFP AFP Ann: AFT further extends Maxigesic footprint strengthens EU
	AFP AFP Ann: Change of Capital notice
	AFP AFP Ann: ASM 2021 results
	AFP AFP Ann: ASM presentation
	AFP AFP Ann: ASM chairs address
	AFP AFP Ann: New clinical study Novaliq NovaTears Omega-3 eye drops
	AFP AFP Ann: Application for quotation of securities - AFP
	AFP AFP Ann: D&O Ongoing Disclosure - Louise Clayton
	AFP AFP Ann: Capital Change Notice - Issue of ordinary shares
	AFP AFP Ann: Maxigesic Oral Liquid gets first regulatory approval
	AFP AFP Ann: Maxigesic IV launches in Germany and Austria
	AFP AFP Ann: ASM 2021 Proxy form
	AFP AFP Ann: Notice of Annual Meeting of Shareholders 2021
	AFP AFP Ann: Application for quotation of securities - AFP
	AFP AFP Ann: Appendix 2A
	AFP AFP Ann: Capital Change Notice
	AFP AFP Ann: FY 2021 AFT Financial Presentation
	AFP AFP Ann: FY2021 Annual Report
	AFP AFP Ann: FY2021 Announcement App 2
	AFP AFP Ann: FY2021 Announcement
	AFP AFP Ann: Appendix 2A
	AFP AFP Ann: AFT extends Maxigesic IV license in South America

Register to track AFP and receive email alerts.

End of Day Prices

Date	Close	Volume	Change
30-Jun	$2.43	5,246	+0.07 (2.97%)
27-Jun	$2.36	88	+0.09 (3.96%)
26-Jun	$2.27	0	0.00 (0.00%)
24-Jun	$2.27	23	+0.01 (0.44%)
23-Jun	$2.26	205	-0.09 (3.83%)
20-Jun	$2.35	640	-0.05 (2.08%)
19-Jun	$2.40	425	+0.05 (2.13%)
18-Jun	$2.35	944	-0.11 (4.47%)
16-Jun	$2.46	385	0.00 (0.00%)
13-Jun	$2.46	1,159	-0.04 (1.60%)
12-Jun	$2.50	100	-0.10 (3.85%)
06-Jun	$2.60	389	+0.10 (4.00%)
05-Jun	$2.50	0	0.00 (0.00%)
04-Jun	$2.50	0	0.00 (0.00%)
03-Jun	$2.50	202	-0.10 (3.85%)
5 up, 6 down, and 4 flat days